Zota Healthcare Ltd

Zota Healthcare Earnings Call Transcript: Key Takeaways

Zota reported robust revenue growth driven by Dawaa India, though consolidated PAT remains in loss.

Zota Healthcare Results Update

Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.

Zota Healthcare Q2 FY27 Results: Net Loss of ₹26 Cr, Loss Widens

Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.

Key figure

Net loss ₹26 Cr

Zota Healthcare Board Meeting Date

Zota Health Care will hold a board meeting on October 28, 2026. The meeting will consider the company's half-yearly unaudited financial results.

Zota Healthcare Price Movement Clarification

Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.

Zota Healthcare Business Update

Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.

store expansion

20.0 stores

Zota Healthcare Capital Structure Change

Zota Health Care Limited acquired 21,00,000 equity shares of its subsidiary, KMHP Ventures Limited, for ₹2.10 Crore. This investment supports the expansion of the 'Ugo Generic' retail pharmacy chain.

Value

₹2.10 Cr

Zota Healthcare Acquisition Worth ₹19.91 Cr

Zota Health Care Limited acquired 39,228 equity shares of its subsidiary, Davaindia Health Mart Limited, for Rs. 19.91 Crore. The investment was made via a rights issue subscription.

Value

₹19.91 Cr

pharmacy stores

1855.0 stores

Zota Healthcare Acquisition Worth ₹2.1 Cr

Zota Health Care Limited acquired 21,00,000 equity shares of its wholly-owned subsidiary, KMHP Ventures Limited, for Rs. 2.10 Crore. This strategic investment supports the rollout of the "Ugo Generic" retail store chain.

Value

₹2.10 Cr

Zota Healthcare Acquisition Worth ₹4.04 Cr

Zota Health Care Limited acquired 20,20,000 equity shares in its wholly owned subsidiary, Curexis Ventures Private Limited, for Rs. 4.04 Crore. The transaction was completed via a rights issue subscription.

Value

₹4.04 Cr

Zota Healthcare Annual General Meeting

Zota Health Care Limited announced that shareholders approved all resolutions at its 26th AGM. A final dividend of Re. 1 per share (10%) was declared.

Zota Healthcare Annual General Meeting

Zota Health Care responded to a proxy advisory firm's negative recommendations on upcoming AGM resolutions, defending proposed director remuneration and related party transactions with its subsidiary.

Zota Healthcare Management Change

Zota Health Care Limited announced the cessation of Mrs. Varshabahen Gaurang Mehta as an Independent Director effective September 09, 2026, upon the completion of her tenure.

Zota Healthcare Management Change

Zota Health Care Limited appointed Mr. Mahaveer Dhariwal as a Non-Executive Independent Director, effective September 3, 2026. The board approved this leadership appointment.

Zota Healthcare Annual General Meeting

Zota Health Care has fixed September 21, 2026, as the record date for its upcoming Annual General Meeting and final dividend payment.

Zota Healthcare Board Meeting Outcome

Zota Health Care Limited's board approved the Notice of the 26th AGM and set the record date for the final dividend. They also appointed a new Independent Director.

Zota Healthcare Earnings Call Transcript: Key Takeaways

Zota reported 67.6% YoY revenue growth in Q1 FY27, driven by Davaindia network expansion. Management expects EBITDA positivity to resume from Q2 and cash breakeven by Q1 FY28.

Zota Healthcare Investor Presentation: Key Takeaways

Zota Health Care's Q1FY27 presentation highlights its massive Davaindia retail generic pharmacy expansion, now reaching 2,825 stores and driving 83% of company revenue.

Zota Healthcare Other Announcement

Zota Health Care Ltd submitted its statement regarding QIP proceeds utilization. The company confirmed no deviation in fund usage for the quarter ended June 30, 2026.

Zota Healthcare Results Update

Zota Health Care reported Q1FY27 consolidated revenue of ₹173.60 Crore, up 67.59% YoY. It also added 264 new stores, expanding its network to 2,825 outlets.

Value

₹173.6 Cr

Zota Healthcare Q1 FY27 Results: Net Loss of ₹43.9 Cr, Loss Widens

Zota Healthcare Ltd reported revenue from operations of ₹173.6 Cr (+67.6% YoY) and a net loss of ₹43.9 Cr for Q1 FY27.

Key figure

Net loss ₹43.9 Cr

Zota Healthcare Board Meeting Date

Zota Health Care Limited will hold a board meeting on August 13, 2026, to consider and approve its quarterly unaudited financial results.

Zota Healthcare Results Correction

Zota Health Care issued a corrigendum to its Consolidated Cash Flow Statement for the year ended March 31, 2026, to rectify typographical errors.

Zota Healthcare Merger & Restructuring Worth ₹119.5 Cr

Zota Health Care converted a Rs. 119.52 Crore unsecured loan into equity of its subsidiary Davaindia Health Mart. This debt-to-equity swap improves the group's consolidated net worth.

Value

₹119.5 Cr

Zota Healthcare Merger & Restructuring Worth ₹119.5 Cr

Zota Health Care acquired 2,35,512 shares in its subsidiary, Davaindia Health Mart, for Rs. 119.52 Crore. The transaction involved converting outstanding unsecured loans into equity.

Value

₹119.5 Cr

Zota Healthcare Capacity Expansion

Zota Health Care disclosed opening 264 Davaindia stores in Q1FY27, raising total stores to 2,825. The expansion underscores robust growth in its retail footprint.

Zota Healthcare Earnings Call: Key Takeaways

Zota reported robust FY26 performance with 83.86% revenue growth, achieving EBITDA turnaround and significant Davaindia store expansion to 2,579 outlets.

Zota Healthcare Earnings Call: Key Takeaways

Zota Health Care (FY26) achieved ₹53,865.75 lakhs revenue, driven by its Davaindia generic pharmacy retail chain which now spans 2,579 stores across 23 states.

Zota Healthcare Results Update

Zota Health Care reported ₹538.66 Crore revenue for FY26, achieving 83.86% YoY growth. Strong expansion saw the Davaindia network reach 2,579 stores nationwide.

Value

₹538.7 Cr

Zota Healthcare Business Update

Zota Health Care capped cumulative promoter director remuneration at ₹12.00 Crore annually until 2030. This voluntary move aims to improve corporate governance and capital allocation.

Value

₹12.00 Cr

Execution

Valid till the end of the financial year 2030